These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37709624)
1. Epidemiology of cholangiocarcinoma. Qurashi M; Vithayathil M; Khan SA Eur J Surg Oncol; 2023 Sep; ():107064. PubMed ID: 37709624 [TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinoma miscoding in hepatobiliary centres. Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867 [TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification. Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117 [TBL] [Abstract][Full Text] [Related]
4. Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma. Xu L; Wang P; Zhang W; Li W; Liu T; Che X Front Oncol; 2021; 11():757498. PubMed ID: 34660327 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748 [TBL] [Abstract][Full Text] [Related]
6. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017. Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334 [TBL] [Abstract][Full Text] [Related]
7. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002 [TBL] [Abstract][Full Text] [Related]
8. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Rizzo A; Brandi G Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174 [TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics and mortality risk between patients with cholangiocarcinoma: A retrospective cohort study. Liu Y; Wang Y; Yu Y; Luo H; Zhen M; Ren J Front Surg; 2022; 9():1037310. PubMed ID: 36873806 [TBL] [Abstract][Full Text] [Related]
11. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma. Esmail A; Badheeb M; Alnahar BW; Almiqlash B; Sakr Y; Al-Najjar E; Awas A; Alsayed M; Khasawneh B; Alkhulaifawi M; Alsaleh A; Abudayyeh A; Rayyan Y; Abdelrahim M Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065760 [TBL] [Abstract][Full Text] [Related]
13. New epidemiologic trends in cholangiocarcinoma. Pascale A; Rosmorduc O; Duclos-Vallée JC Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102223. PubMed ID: 37797807 [TBL] [Abstract][Full Text] [Related]
14. Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. Zheng Y; Qin Y; Gong W; Li H; Li B; Wang Y; Chao B; Zhao S; Liu L; Yao S; Shi J; Shi X; Wang K; Xu S J Gastrointest Oncol; 2021 Dec; 12(6):2631-2642. PubMed ID: 35070393 [TBL] [Abstract][Full Text] [Related]
16. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification. Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120 [TBL] [Abstract][Full Text] [Related]
18. Cell of origin in biliary tract cancers and clinical implications. Moeini A; Haber PK; Sia D JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585 [TBL] [Abstract][Full Text] [Related]
19. Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology. Gringeri E; Gambato M; Sapisochin G; Ivanics T; Lynch EN; Mescoli C; Burra P; Cillo U; Russo FP J Clin Med; 2020 May; 9(5):. PubMed ID: 32380750 [TBL] [Abstract][Full Text] [Related]